Here at the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS), we are working on new ways to delay and prevent heart failure for people with congenital heart defects. In order to do that, we are studying regenerative (stem cells) therapies, genetics and imaging techniques along with creating the world's largest biorepository for patients with HLHS and their families.
To better understand the major role that genetics plays in the work we are doing, check out the short video below.
Do you have questions or are you interested in our program? Email us at HLHS@mayo.edu.
The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science to diagnostic imaging to regenerative therapies.